Job R. Schippers

Amsterdam, NH 1081HV, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Measuring and managing pulmonary edema in ARDS: a narrative review.

Measuring and managing pulmonary edema in ARDS: a narrative review.

Journal: Critical care (London, England)

Published: February 08, 2026

Exposure-response analysis of oral and intravenous imatinib in critically ill patients with COVID-19 acute respiratory distress syndrome.

Exposure-response analysis of oral and intravenous imatinib in critically ill patients with COVID-19 acute respiratory distress syndrome.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: June 20, 2025

Deep phenotyping of pulmonary edema and pulmonary vascular permeability in COVID-19 ARDS.

Deep phenotyping of pulmonary edema and pulmonary vascular permeability in COVID-19 ARDS.

Journal: American journal of physiology. Lung cellular and molecular physiology

Published: October 22, 2024

Disease-Drug-Drug Interaction of Imatinib in COVID-19 ARDS: A Pooled Population Pharmacokinetic Analysis.

Disease-Drug-Drug Interaction of Imatinib in COVID-19 ARDS: A Pooled Population Pharmacokinetic Analysis.

Journal: CPT: pharmacometrics & systems pharmacology

Published: November 01, 2023

The diagnostic accuracy of lung ultrasound to determine PiCCO-derived extravascular lung water in invasively ventilated patients with COVID-19 ARDS.

The diagnostic accuracy of lung ultrasound to determine PiCCO-derived extravascular lung water in invasively ventilated patients with COVID-19 ARDS.

Journal: The ultrasound journal

Published: July 25, 2023

Absence of COVID-19 associated mucormycosis in a tertiary intensive care unit in the Netherlands.

Absence of COVID-19 associated mucormycosis in a tertiary intensive care unit in the Netherlands.

Journal: Scientific reports

Published: May 22, 2023

Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial.

Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial.

Journal: Critical care (London, England)

Published: April 04, 2023

Pharmacokinetics and pharmacodynamics of imatinib for optimal drug repurposing from cancer to COVID-19.

Pharmacokinetics and pharmacodynamics of imatinib for optimal drug repurposing from cancer to COVID-19.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: September 27, 2022

Cardiac Safety of Imatinib for the Treatment of COVID-19: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial.

Cardiac Safety of Imatinib for the Treatment of COVID-19: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial.

Journal: Journal of cardiovascular pharmacology

Published: April 28, 2022

Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients.

Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients.

Journal: The European respiratory journal

Published: April 13, 2022

Long-term clinical outcomes of COVID-19 patients treated with imatinib.

Long-term clinical outcomes of COVID-19 patients treated with imatinib.

Journal: The Lancet. Respiratory medicine

Published: January 24, 2022

The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19.

The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19.

Journal: Trials

Published: June 01, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026